Dr. Reddy’s to acquire Slayback’s eyedrop rights
Pharma major Dr. Reddy’s Laboratories has entered into a licensing agreement to obtain rights to New Jersey-based Slayback Pharma’s Brimonidine Tartrate Ophthalmic Solution 0.025%.Slayback…
Browsing Tag
abbreviated new drug application
USFDA approves Zydus copy of cholesterol drug Colestid
“The Abbreviated New Drug Application of the company is only the second generic application approved by USFDA for this product,” Zydus said
“The Abbreviated New Drug Application of the…
USFDA nod for Natco Pharma’s anti-cancer generic drug
While the 10mg and 60mg strengths, of the product, have received final approval from the regulator, the 30mg strength has got a tentative approval.
Natco Pharma on Monday said the U.S.…